Clinical Trial Update: Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a trivalent ganglioside vaccine with an immunological adjuvant vs immunological adjuvant alone in metastatic sarcoma patients who becam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Immunological Adjuvant Alone
• Trivalent Ganglioside Vaccine With Immunological Adjuvant

Snippet

Sponsor: MabVax Therapeutics, Inc. | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2016-12-07